Betamethasone Valerate, Gentamicin Sulfate

8 trials 7 recruiting JAnti-infectives

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

7 Recruiting

0 Completed trials

8 Sponsors

8 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 2 Phase IV: 4

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Sepsis 2 Abdominal infection 1 Infection 1 Urinary tract infection 1 Implant site infection 1 Bacterial infection 1 Antibiotic level therapeutic 1 Preterm premature rupture of membranes 1

Sponsors using this IMP

Akershus University Hospital 1 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Universitaire De Nantes 1 Fakultni Nemocnice Plzen 1 Odense University Hospital 1 Pfizer Inc. 1 Region Midtjylland 1 Uppsala Universitet 1

All trials

8 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
TRI-AB trial Recruiting

2024-520251-24-00 Phase IV 1 country Odense University Hospital
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Aminoglycosides in early sepsis Recruiting

2024-519797-39-00 Phase IV 1 country Akershus University Hospital
TAILORED-PROM: Personalized therapeutic approach for preterm premature rupture of membranes to safely prolong pregnancy, enhance maternal an… Recruiting

2024-520237-77-00 Phase III 1 country Vseobecna Fakultni Nemocnice V Praze
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.

Showing 1–8 of 8 trials

← All drugs A–Z